We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
PUT
Alphabet (Google) Class A
GOOGL
$3.91T
| $25.2M | 0.06% |
285,300
+113,800
| +66% | +$10.8M |
|
377
PUT
Moderna
MRNA
$21.5B
| $25.1M | 0.06% |
139,700
+18,600
| +15% | +$3.04M |
|
378
PUT
Microsoft
MSFT
$2.84T
| $25.1M | 0.06% |
104,500
+48,200
| +86% | +$11.6M |
|
|
MGI
379
DELISTED
MoneyGram International, Inc. New
MGI
| $25M | 0.06% |
2,298,730
+418,041
| +22% | +$4.47M |
|
|
AGR
380
DELISTED
Avangrid, Inc.
AGR
| $25M | 0.06% |
581,940
+57,982
| +11% | +$2.4M |
|
381
Wendy's
WEN
$1.33B
| $25M | 0.06% |
+1,102,893
| New | +$23.6M |
|
382
iShares Silver Trust
SLV
$28.1B
| $24.9M | 0.06% |
1,131,200
+533,800
| +89% | +$10.5M |
|
383
Celsius Holdings
CELH
$6.93B
| $24.9M | 0.06% |
717,099
+69,693
| +11% | +$2.27M |
|
384
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $24.6M | 0.06% |
+327,007
| New | +$24.4M |
|
385
Levi Strauss
LEVI
$9.44B
| $24.4M | 0.06% |
1,574,260
+1,383,339
| +725% | +$21.5M |
|
|
FSNB
386
DELISTED
Fusion Acquisition Corp. II
FSNB
| $24.3M | 0.05% |
2,416,639
| – | – |
|
|
MIT
387
DELISTED
Mason Industrial Technology, Inc.
MIT
| $24.2M | 0.05% |
2,423,479
| – | – |
|
388
Check Point Software Technologies
CHKP
$13.3B
| $24.2M | 0.05% |
191,478
-275,061
| -59% | -$34.3M |
|
389
Sarepta Therapeutics
SRPT
$1.66B
| $24.1M | 0.05% |
+186,005
| New | +$21.6M |
|
|
GHIX
390
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
| $23.7M | 0.05% |
2,387,493
| – | – |
|
391
Marriott International
MAR
$98.7B
| $23.4M | 0.05% |
157,134
-255,260
| -62% | -$39.3M |
|
392
CALL
UnitedHealth
UNH
$382B
| $23.2M | 0.05% |
43,800
+8,200
| +23% | +$4.34M |
|
|
SCRM
393
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $23.2M | 0.05% |
2,333,385
| – | – |
|
|
BPMC
394
DELISTED
Blueprint Medicines
BPMC
| $23.2M | 0.05% |
+529,456
| New | +$25.4M |
|
395
Chord Energy
CHRD
$7.79B
| $23M | 0.05% |
168,384
+154,275
| +1,093% | +$22.6M |
|
396
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $23M | 0.05% |
391,600
-468,600
| -54% | -$28.8M |
|
397
Omega Healthcare
OHI
$15.4B
| $23M | 0.05% |
822,420
+88,507
| +12% | +$2.67M |
|
398
Algonquin Power & Utilities
AQN
$4.69B
| $23M | 0.05% |
+3,521,861
| New | +$31.4M |
|
399
CSX Corp
CSX
$98.6B
| $22.9M | 0.05% |
739,250
+155,180
| +27% | +$4.67M |
|
|
OKLO
400
Oklo
OKLO
$7B
| $22.8M | 0.05% |
2,300,339
| – | – |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.